Our Mission

To make a major impact on the economies of nations by significantly reducing healthcare costs and to transform the lives of individuals through providing access to effective, minimally toxic and affordable next generation immunotherapy for the treatment of cancer and infectious diseases and for and immunomodulatory vaccines for prevention of diseases of aging, such as cancer, cardiovascular diseases (such as atherosclerosis) and neurological diseases (such as Alzheimer’s and Parkinson’s disease). 

Our Vision

To create a new biopharmaceutical industry that provides next generation, branded immunotherapy drugs that return pharmaceutical margins to our shareholders and are affordable to the masses.